Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,684Revenue (TTM) $M2,242Net Margin (%)10.1Altman Z-Score5.9
Enterprise Value $M7,753EPS (TTM) $1.3Operating Margin %15.5Piotroski F-Score5
P/E(ttm)35.1Beneish M-Score-3.1Pre-tax Margin (%)14.0Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %26.9Quick Ratio1.1Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %16.9Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow22.1y-y EBITDA Growth Rate %-9.2ROA % (ttm)7.4Higher Current Ratio y-yN
Dividend Yield %0.7PEG2.1ROE % (ttm)12.3Less Shares Outstanding y-yN
Payout Ratio %23.0Shares Outstanding M166ROIC % (ttm)12.5Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RDYKen Fisher 2016-06-30 Add0.05%$41.9 - $51.23
($45.82)
$ 46.421%Add 9.46%5,227,024
RDYKen Fisher 2016-03-31 Add0.02%$41.22 - $48.86
($44.64)
$ 46.424%Add 6.00%4,775,345
RDYKen Fisher 2015-12-31 Reduce-0.06%$43.55 - $67.79
($54.62)
$ 46.42-15%Reduce -9.20%4,504,956
RDYKen Fisher 2015-09-30 Reduce-0.03%$55.59 - $67.73
($62.11)
$ 46.42-25%Reduce -4.55%4,961,550
RDYKen Fisher 2015-06-30 Reduce$51.8 - $60.54
($55.23)
$ 46.42-16%Reduce -0.34%5,198,254
RDYKen Fisher 2015-03-31 Add0.12%$47.73 - $57.1
($53.03)
$ 46.42-12%Add 25.58%5,216,225
RDYKen Fisher 2014-06-30 Add0.13%$38.67 - $46.08
($42.03)
$ 46.4210%Add 62.43%3,773,114
RDYKen Fisher 2014-03-31 Add0.08%$39.5 - $47.4
($43.29)
$ 46.427%Add 56.30%2,322,863
RDYKen Fisher 2013-06-30 Add0.04%$32.98 - $38.7
($36.5)
$ 46.4227%Add 48.42%1,283,605
RDYKen Fisher 2013-03-31 Add0.02%$32.03 - $36.57
($34.21)
$ 46.4236%Add 31.46%864,830
RDYKen Fisher 2012-09-30 Buy 0.05%$28.94 - $32.58
($30.12)
$ 46.4254%New holding604,555
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RDY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about RDY:

    News about RDY:

    Articles On GuruFocus.com
    Growing Generic Drug Market a Good Opportuity for 2 India Firms May 30 2016 
    Ken Fisher Sells Shares of PMC Sierra, Alphabet During 4th Quarter Jan 15 2016 
    Emerging Market Stocks To Watch Out For Feb 17 2015 
    Should You Buy Actavis? Mar 18 2014 
    Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
    5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
    Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 

    More From Other Websites
    Insight: The cost of cheap drugs? Toxic Indian lake is "superbug hotspot" Sep 28 2016
    Insight: The cost of cheap drugs? Toxic Indian lake is "superbug hotspot" Sep 28 2016
    ETF’s with exposure to Dr. Reddy’s Laboratories Ltd. : September 26, 2016 Sep 26 2016
    Dr. Reddy's Laboratories announces the launch of Paricalcitol Injection in the U.S. Market Sep 19 2016
    Dr. Reddy's Laboratories Announces the Launch of Paricalcitol Injection in the U.S. Market Sep 19 2016
    Dr. Reddy's Laboratories Announces the Launch of Paricalcitol Injection in the U.S. Market Sep 19 2016
    Dr. Reddy’s Expands Strategic Collaboration with Amgen in India Sep 16 2016
    Dr. Reddy’s Expands Strategic Collaboration with Amgen in India Sep 16 2016
    Dr. Reddy’s Expands Strategic Collaboration with Amgen in India Sep 16 2016
    Dr Reddy’s listed on Dow Jones Sustainability Indices 2016 Sep 14 2016
    Dr. Reddy’s Listed on Dow Jones Sustainability Indices 2016 Sep 13 2016
    Dr. Reddy’s Listed on Dow Jones Sustainability Indices 2016 Sep 13 2016
    Dr. Reddy's Laboratories announces the launch of Bupropion HCl Extended-Release Tablets, USP (SR) in... Sep 06 2016
    Dr. Reddy's Laboratories Announces the Launch of Bupropion HCl Extended-Release Tablets, USP (SR) in... Sep 02 2016
    Dr. Reddy's Laboratories Announces the Launch of Bupropion HCl Extended-Release Tablets, USP (SR) in... Sep 02 2016
    Dr. Reddy’s announces Purple Health, a unique patient-centric platform that takes care beyond the... Sep 01 2016
    Dr. Reddy’s Announces Purple Health, a Unique Patient-Centric Platform That Takes Care beyond the... Sep 01 2016
    Dr. Reddy’s Announces Purple Health, a Unique Patient-Centric Platform That Takes Care beyond the... Sep 01 2016
    Dr. Reddy's Laboratories launches Nitroglycerin sublingual tablets USP in the U.S. Market Aug 29 2016
    Dr. Reddy's Laboratories Launches Nitroglycerin Sublingual Tablets USP in the U.S. Market Hyderabad,... Aug 29 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)